These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 39387050)
1. Utilize proteomic analysis to identify potential therapeutic targets for combating sepsis and sepsis-related death. Zhang T; Shi Y; Li J; Huang P; Chen K; Yao J Front Endocrinol (Lausanne); 2024; 15():1448314. PubMed ID: 39387050 [TBL] [Abstract][Full Text] [Related]
2. PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses. Han QJ; Zhu YP; Sun J; Ding XY; Wang X; Zhang QZ Front Pharmacol; 2024; 15():1418560. PubMed ID: 39035989 [TBL] [Abstract][Full Text] [Related]
3. Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study. Zhao H; Zhou Y; Wang Z; Zhang X; Chen L; Hong Z Front Immunol; 2024; 15():1417564. PubMed ID: 39026678 [TBL] [Abstract][Full Text] [Related]
4. ​Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction. Sun Z; Yun Z; Lin J; Sun X; Wang Q; Duan J; Li C; Zhang X; Xu S; Wang Z; Xiong X; Yao K J Transl Med; 2024 Apr; 22(1):404. PubMed ID: 38689297 [TBL] [Abstract][Full Text] [Related]
5. Identifying novel potential drug targets for endometriosis via plasma proteome screening. Tao T; Mo X; Zhao L Front Endocrinol (Lausanne); 2024; 15():1416978. PubMed ID: 39036049 [TBL] [Abstract][Full Text] [Related]
6. Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a Mendelian randomization study and colocalization analysis. Song J; Yang H Front Endocrinol (Lausanne); 2024; 15():1449668. PubMed ID: 39351539 [TBL] [Abstract][Full Text] [Related]
7. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis. Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J Front Immunol; 2024; 15():1366736. PubMed ID: 38566994 [TBL] [Abstract][Full Text] [Related]
8. Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study. Si S; Li J; Tewara MA; Xue F Front Immunol; 2021; 12():720876. PubMed ID: 34386016 [TBL] [Abstract][Full Text] [Related]
9. Proteomic Mendelian randomization to identify protein biomarkers of telomere length. Zhao J; Yang K; Lu Y; Zhou L; Fu H; Feng J; Wu J Sci Rep; 2024 Sep; 14(1):21594. PubMed ID: 39284832 [TBL] [Abstract][Full Text] [Related]
10. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening. Yuan W; Xu W; Xu X; Qu B; Zhao F Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174 [TBL] [Abstract][Full Text] [Related]
11. Plasma Proteomic Insights for Identification of Novel Predictors and Potential Drug Targets in Atrial Fibrillation: A Prospective Cohort Study and Mendelian Randomization Analysis. Peng X; Li Y; Liu N; Xia S; Li X; Lai Y; He L; Sang C; Dong J; Ma C Circ Arrhythm Electrophysiol; 2024 Oct; 17(10):e013037. PubMed ID: 39355913 [TBL] [Abstract][Full Text] [Related]
12. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis. Zou M; Shao Z Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773 [TBL] [Abstract][Full Text] [Related]
13. Proteome-wide mendelian randomization identifies therapeutic targets for nephrolithiasis. Wang L; Li KP; Chen SY; Wan S; Li XR; Yang L Urolithiasis; 2024 Sep; 52(1):126. PubMed ID: 39237840 [TBL] [Abstract][Full Text] [Related]
14. Exploring novel drug targets for atopic dermatitis through plasma proteome with genome. Wu W; Su H; Chen Z; Wei S Arch Dermatol Res; 2024 Aug; 316(8):521. PubMed ID: 39136778 [TBL] [Abstract][Full Text] [Related]
15. Unveiling potential therapeutic targets for diabetes-induced frozen shoulder through Mendelian randomization analysis of the human plasma proteome. Chen K; Tian T; Gao P; Fang X; Jiang W; Li Z; Tang K; Ouyang P; Li L BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38719509 [TBL] [Abstract][Full Text] [Related]
16. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma. Zhang L; Xiong Y; Zhang J; Feng Y; Xu A J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses. Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861 [TBL] [Abstract][Full Text] [Related]
18. Promising therapeutic targets for ischemic stroke identified from plasma and cerebrospinal fluid proteomes: a multicenter Mendelian randomization study. Zou X; Wang L; Wang S; Zhang Y; Ma J; Chen L; Li Y; Yao TX; Zhou H; Wu L; Tang Q; Ma S; Zhang X; Tang R; Yi Y; Liu R; Zeng Y; Zhang L Int J Surg; 2024 Feb; 110(2):766-776. PubMed ID: 38016292 [TBL] [Abstract][Full Text] [Related]
19. Proteome-Wide Multicenter Mendelian Randomization Analysis to Identify Novel Therapeutic Targets for Lung Cancer. Wang K; Yi H; Wang Y; Jin D; Zhang G; Mao Y Arch Bronconeumol; 2024 Sep; 60(9):553-558. PubMed ID: 38824092 [TBL] [Abstract][Full Text] [Related]
20. Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers. Zhang Y; Liu W; Lai J; Zeng H Front Immunol; 2024; 15():1394438. PubMed ID: 38835753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]